Related Experiment Videos
Coccidioidomycosis: a reemerging infectious disease
1Department of Pathology, University of California, San Diego School of Medicine, California 92161, USA. tkirkland@ucsd.edu
Emerging Infectious Diseases
|July 1, 1996
Summary
Coccidioides immitis infections, or coccidioidomycosis, are increasing in California. This fungal disease causes significant health and economic burdens, particularly for immunocompromised individuals.
Area of Science:
- Mycology
- Infectious Diseases
- Epidemiology
Background:
- Coccidioides immitis is a fungus endemic to arid regions of the southwestern US and Central/South America.
- Coccidioidomycosis incidence surged in California during the early 1990s, leading to substantial economic costs.
- The pathogen poses severe risks, especially disseminated infections in immunocompromised populations like AIDS patients.
Purpose of the Study:
- To explore factors contributing to the rise in coccidioidomycosis.
- To examine the challenges of coccidioidomycosis in immunocompromised patients.
- To review novel therapeutic and preventive strategies for this fungal infection.
Main Methods:
- Review of epidemiological data on coccidioidomycosis incidence.
- Analysis of potential contributing factors: climatic and demographic shifts.
- Examination of clinical manifestations and treatment outcomes in immunocompromised individuals.
Main Results:
- The study identifies climatic and demographic changes as potential drivers of increased coccidioidomycosis.
- It highlights the severe clinical impact on immunocompromised individuals, including those with AIDS.
- Emerging therapeutic and preventive approaches are discussed.
Conclusions:
- The rise in coccidioidomycosis necessitates understanding contributing factors and improving patient management.
- Special attention is required for the immunocompromised population due to increased risk of severe disease.
- Continued research into novel therapies and prevention is crucial for public health.